In conclusion, our study found a higher hazard ratio for 7-day mortality in Asian AF patients with major bleeding related to Factor Xa inhibitors than dabigatran, although differences in 30-day mortality did not reach statistical significance. This evidence concerns the gene F10 and atrial fibrillation.